The University of Chicago Header Logo

Connection

Peter H. O'Donnell to Germ-Line Mutation

Back to Details
This is a "connection" page, showing publications Peter H. O'Donnell has written about Germ-Line Mutation.
Peter H. O'Donnell
Connection Strength
0.831
Germ-Line Mutation
  1. Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer. Clin Genitourin Cancer. 2016 12; 14(6):511-517.
    View in: PubMed
    Score: 0.456
  2. Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015. Breast Cancer Res Treat. 2020 Jun; 181(3):623-633.
    View in: PubMed
    Score: 0.152
  3. Analyzing the clinical actionability of germline pharmacogenomic findings in oncology. Cancer. 2018 07 15; 124(14):3052-3065.
    View in: PubMed
    Score: 0.132
  4. Bladder cancer pharmacogenomics: recent insights and future perspectives. Pharmacogenomics. 2012 Nov; 13(14):1553-6.
    View in: PubMed
    Score: 0.090
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.